Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Rankning i aktier #27858
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Aktiekurs
$1.00
Senast synkroniserad: 2023-06-01
Marknadsvärde
$30.11M
Förändring (1 dag)
2.04%
Förändring (1 år)
0.00%
Land
US
Handel Angion Biomedica Corp. (ANGN)

Kategori

Aktiekurshistorik för Angion Biomedica Corp. (ANGN)
Högsta slutkurs: $1.00 den 2023-06-01

Lägsta slutkurs: $20.49 den 2021-02-01
Aktiekurshistorik för Angion Biomedica Corp. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 18.73%
2022 -70.78%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.65 -14.34%
AU
$753.28 5.84%
CH